4
Changes in Ownership
Oric Pharmaceuticals, Inc. Filed Acc 0001415889-24-029634
Chief Financial Officer sold 8,851 shares at $8.28 ($73,298)
- Chief Financial Officer acquired 24,042 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Piscitelli Dominic Chief Financial Officer | 2024-12-15 | Option exercise | +24,042 | 115,615 | D | ||
| Piscitelli Dominic Chief Financial Officer | 2024-12-16 | Sale | −8,851 | $8.28 | $73,298 | 106,764 | D |
| Derivatives | |||||||
| Piscitelli Dominic Chief Financial Officer | 2024-12-15 | Option exercise · Restricted Stock Unit | −6,042 | 0 | D | ||
| Piscitelli Dominic Chief Financial Officer | 2024-12-15 | Option exercise · Restricted Stock Unit | −8,000 | 8,000 | D | ||
| Piscitelli Dominic Chief Financial Officer | 2024-12-15 | Option exercise · Restricted Stock Unit | −10,000 | 20,000 | D | ||
| Open-market sales · 8,851 sh · avg $8.28 · $73,298 | |||||||
Loading xslF345X05/form4-12172024_101232.xml…